July 03 The first fully A.I.-generated drug enters clinical trials in human patients A medicine entirely produced by artificial intelligence (AI), developed by a Hong Kong biotech startup called Insilico Medicine, has begun clinical trials with human patients. The drug, named INS018_055, aims to treat idiopathic pulmonary…
It looks like you're new here. Sign in or register to get started.